US Broker Ratings

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Exploring a Promising 154% Potential Upside in the Biotech Arena

Investors with a keen eye on the biotech sector should take note of Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a commercial-stage company that is making significant strides in addressing unmet needs..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 38.81% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is making waves in the medical devices industry. With a focus on pediatric orthopedic solutions, the company is dedicated..

KalVista Pharmaceuticals (KALV) Stock Analysis: Uncovering a 112% Potential Upside in the Biotech Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector, offering promising drug therapies for diseases with unmet medical needs. Headquartered in Framingham, Massachusetts, this innovative biopharmaceutical company..

Neuropace, Inc. (NPCE) Investor Outlook: A Medical Device Innovator with 26% Potential Upside

For investors with an eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) represents a compelling opportunity in the medical devices industry. Specializing in innovative neuromodulation systems for the treatment..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Is an 82% Potential Upside Within Reach?

Bicara Therapeutics Inc. (NASDAQ: BCAX) is capturing the attention of investors with its promising clinical-stage biopharmaceutical developments and an eye-catching analyst consensus that suggests an 82% potential upside from its..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 21.99% Potential Upside with Strong Buy Ratings

Butterfly Network, Inc. (NASDAQ: BFLY), a notable player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative ultrasound imaging solutions. This U.S.-based company..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A Promising 119.94% Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR), a dynamic player in the biotechnology sector, is drawing significant attention from investors with its robust clinical development pipeline and significant projected stock upside. Despite..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring an 88.66% Potential Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors with its substantial 88.66% potential upside, as indicated by analyst target prices...

Xencor, Inc. (XNCR) Stock Analysis: Unlocking a 132.90% Upside Potential in Biotech Innovation

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company, is poised for significant growth in the healthcare sector, particularly within the biotechnology industry. With a current market capitalization of $884.06 million, Xencor..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Promising Upside with a 163.77% Potential

Niagen Bioscience, Inc. (NAGE), a key player in the biotechnology sector, is capturing investor attention with its significant potential upside and innovative approach to healthy aging. Headquartered in Los Angeles,..

Valneva SE (VALN) Investor Outlook: Exploring a 36.96% Upside Potential in the Biotech Frontier

Valneva SE (NASDAQ: VALN), a French biotechnology company, is carving a niche in the healthcare sector by targeting unmet needs in the realm of prophylactic vaccines. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: A Promising 27.53% Upside Potential in Biotech

Investors focusing on the biotechnology sector should turn their attention to Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the healthcare industry with a market capitalization of $1.77 billion...

Claritev Corporation (CTEV) Stock Analysis: Exploring a 112.59% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Claritev Corporation (NASDAQ: CTEV) presents an intriguing prospect. As a company specializing in data analytics and technology-enabled cost management within the healthcare..

CorMedix Inc. (CRMD) Stock Analysis: Exploring an 85% Potential Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector may find CorMedix Inc. (NASDAQ: CRMD) an intriguing prospect. Specializing in biotechnology, CorMedix is a U.S.-based company with a current market..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Potential 125% Upside in the Medical Devices Sector

For investors with an appetite for healthcare innovations, Delcath Systems, Inc. (NASDAQ: DCTH) presents a compelling opportunity within the medical devices industry. This New York-based company specializes in interventional oncology,..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Promising 90% Upside Potential

For investors keen on the biotech sector, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) presents a fascinating opportunity with its significant upside potential. As a clinical-stage biopharmaceutical company, MindMed is dedicated..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Pioneer with 61% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is making waves in the biotechnology sector, attracting investor attention with a compelling potential upside of 61.18%. As a clinical-stage biopharmaceutical company, Enliven is dedicated..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unveiling a 122.64% Upside in the Biotech Sector

For investors with a keen eye on the biotech sector, Nuvation Bio Inc. (NASDAQ: NUVB) presents a compelling opportunity with a staggering potential upside of 122.64%, according to analyst target..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 53.75% Upside in the Biotech Sector

For investors keen on the biotechnology sector, Upstream Bio, Inc. (UPB) has garnered significant attention. With a market capitalization of $1.67 billion, UPB operates within the healthcare sector, focusing specifically..

uniQure N.V. (QURE) Stock Analysis: A Biotech Player with 127.68% Potential Upside

For investors with a keen eye on the biotechnology sector, uniQure N.V. (NASDAQ: QURE) presents a compelling case. Based in Amsterdam, the Netherlands, uniQure focuses on developing treatments for rare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds